Dr. Thomas Kisby (NanoTherapeutics), Dr. Rahaf Issa (NanoCellBiology) and Dr. Ahmed Eladly (NanoNeuro) all gave talks during the Advanced Materials in Medicine Conference on Manchester this January. The Conference gathered the UoM community and clinicians with presentations about biomaterials, tissue engineering, nanomedicine, and bioelectronics.
Tom presented part of the work done by the Nanotherapeutics Team on the “Development of personalised glioblastoma immunotherapies using 2D nanomaterials”.
Rahaf presented her work on the use of novel 3D in vitro models (organoids) as a tool to study potential toxicity of 2D nanomaterials. Ahmed gave a presentation during the “Bioelectronics’ session about his work on in vivo validation  of a graphene-based deep brain stimulation (DBS) electrode that could be used for effective control of motor symptoms in Parkinson’s disease (PD).